Home › Research › Brain scans and imaging
Retinal biomarkers and dementia risk: A review of evidence across the 14 Lancet modifiable risk factors for dementia
Barrett-Young A.. PsyArXiv, 2026-10-22
Topic: Plasma and spinal-fluid biomarkers
Plain-language summary
As the only central nervous system tissue that can be directly imaged non-invasively using widely available technology, the retina offers a uniquely accessible window into the brain. Quantitative retinal measures can be derived at scale and have been associated with mechanistic processes in the brain and throughout the body, positioning retinal biomarkers as promising tools for dementia prevention and intervention research. Evidence indicates that several retinal biomarkers can distinguish individuals with Alzheimer’s disease (AD) from cognitively healthy controls; however, it remains unclear whether these markers reflect preclinical AD-specific pathology or broader profiles of dementia risk, particularly in the earliest stages of disease. This review synthesises current evidence on retinal microvascular and neuronal morphological biomarkers and their associations with 14 modifiable dementia risk factors identified by the Lancet Commission on dementia. Robust evidence indicates that retinal biomarkers are influenced by vascular and metabolic risks, specifically hypertension and diabetes. However, associations with other modifiable risk factors, including social isolation, lower educational attainment, hearing loss, smoking, air pollution, and traumatic brain injury, are sparse or absent. Critical research gaps persist regarding how, when, and for whom the retina reflects vascular and metabolic risk factors, and whether non-biological risk factors, such as social isolation and educational attainment, are better understood as independent or confounding variables than as direct biological determinants of retinal biomarkers. Clarifying these associations is essential to establish retinal biomarkers as scalable, non-invasive indicators of dementia risk and to support their integration into targeted risk stratification, early detection, and preventive intervention studies.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Barrett-Young, A. (2026). Retinal biomarkers and dementia risk: A review of evidence across the 14 Lancet modifiable risk factors for dementia. PsyArXiv. https://doi.org/10.31234/osf.io/xh7g6_v1
Vancouver
Barrett-Young A. Retinal biomarkers and dementia risk: A review of evidence across the 14 Lancet modifiable risk factors for dementia. PsyArXiv. 2026. doi:10.31234/osf.io/xh7g6_v1.
BibTeX
@article{barrettyoung2026-e8939dca,
author = {Barrett-Young, A.},
title = {{Retinal biomarkers and dementia risk: A review of evidence across the 14 Lancet modifiable risk factors for dementia}},
journal = {PsyArXiv},
year = {2026},
doi = {10.31234/osf.io/xh7g6_v1},
url = {https://doi.org/10.31234/osf.io/xh7g6_v1}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Quantitative retinal measures can be derived at scale and have been associated with mechanistic processes in the brain and throughout the body, positioning retinal biomarkers as promising tools for dementia prevention and intervention research.
- Evidence indicates that several retinal biomarkers can distinguish individuals with Alzheimer’s disease (AD) from cognitively healthy controls; however, it remains unclear whether these markers reflect preclinical AD-specific pathology or broader profiles of dementia risk, particularly in the earliest stages of disease.
- Robust evidence indicates that retinal biomarkers are influenced by vascular and metabolic risks, specifically hypertension and diabetes.
New to this subject? Start with our plain-English guide: Brain scans & tests →
Study details
- Evidence strengthLow
How this study scored 16/100
Preprint — not yet peer-reviewed. It scored 21 on the same rubric, but non-peer-reviewed sources are capped at 16, so it shows as 16. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 13 of the 62 points we could judge it on, which is 21 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 2 / 10 | Tier 4 — not a peer-reviewed journal (PsyArXiv) |
| Journal's citation record | 0 / 4 | Not a journal article, so the journal's record does not count |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 4 / 10 | Preprint — not yet peer-reviewed. Hosted on a preprint server. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 13 / 62 | Scored on 12 of 20 parts. We have no data for the rest, so they are left out: 13 of the 62 points we could judge it on is 21 out of 100. |
| Total | 21 / 100 | Capped to 16 because this is not a peer-reviewed article. |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Brain scans and imaging from nearby years
Also tagged “optical”
151 studies in the library carry the topic tag “optical”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 151 tagged studies.